Abstract
Lipoproteins containing apolipoprotein B modify associations of elevated urinary albumin excretion (UAE) with cardiovascular disease (CVD). Additionally, it is known that elevated UAE alters high-density lipoprotein functionality. Accordingly, we examined whether HDL features might also modify UAE-associated CVD. Multivariable Cox proportional-hazards modeling was performed on participants of the PREVEND (Prevention of Renal and Vascular Endstage Disease) study at the baseline screening with standard lipid/lipoprotein analyses and, three-to-four years later (second screen), with nuclear magnetic resonance lipoprotein analyses focusing on HDL parameters including HDL particle (HDL-P) and apolipoprotein A-I concentrations. These were used with UAE and derived measures of HDL apoA-I content (apoA-I/HDL-C and apoA-I/HDL-P) in risk models adjusted for gender, age, apoB, diabetes, past CVD history, CRP and GFR. Interaction analysis was also performed. Baseline screening revealed significant associations inverse for HDL-C and apoA-I and direct for apoA-I/HDL-C. The second screening demonstrated associations inverse for HDL-P, large HDL-P, medium HDL-P, HDL size, and apoA-I/HDL-P. Significant interactions with UAE included apoA-I/HDL-C...Continue Reading
References
Jul 1, 1991·Kidney International·G L WarwickJ Shepherd
Feb 1, 1990·Metabolism: Clinical and Experimental·G L WarwickJ Shepherd
Aug 30, 1990·The New England Journal of Medicine·J JovenM Vallés
Feb 1, 1985·Atherosclerosis·E MulsJ Boelaert
Sep 1, 1993·Kidney International·J D OrdoñezB H Fireman
Jul 1, 1993·Kidney International·R P DullaartA Van Tol
Jun 4, 1996·Biochemistry·Y Zhao, Y L Marcel
Apr 29, 1998·Kidney International·M G de Sain-van der VeldenT J Rabelink
Aug 5, 1999·Kidney International·K Liang, N D Vaziri
Jun 26, 2001·Journal of Internal Medicine·H L HillegeUNKNOWN Prevend Study Group
Jul 31, 2001·JAMA : the Journal of the American Medical Association·H C GersteinUNKNOWN HOPE Study Investigators
Apr 13, 2004·International Journal of Epidemiology·Matthew F YuyunUNKNOWN European Prospective Investigation into Cancer in Norfolk (EPIC-Norfolk) population study
May 11, 2006·The Journal of Clinical Endocrinology and Metabolism·Susanna E BorggreveUNKNOWN PREVEND Study Group
May 23, 2006·BMJ : British Medical Journal·Marcello TonelliUNKNOWN Cholesterol and Recurrent Events (CARE) Trial Investigators
Jul 11, 2006·Journal of the American Society of Nephrology : JASN·Coen D A Stehouwer, Yvo M Smulders
Nov 18, 2006·Clinics in Laboratory Medicine·Elias J JeyarajahJames D Otvos
Feb 17, 2007·Blood Pressure Monitoring·Annemarie de GreeffAndrew H Shennan
Aug 8, 2007·Atherosclerosis·Ian H de BoerBryan Kestenbaum
Jan 14, 2009·Translational Research : the Journal of Laboratory and Clinical Medicine·Hamid MoradiNosratola D Vaziri
Apr 29, 2009·Expert Opinion on Therapeutic Targets·J A KrikkenR P F Dullaart
May 6, 2009·Annals of Internal Medicine·Andrew S LeveyUNKNOWN CKD-EPI (Chronic Kidney Disease Epidemiology Collaboration)
Apr 24, 2010·European Journal of Clinical Investigation·James P CorsettiRobin P F Dullaart
Dec 7, 2010·Journal of Internal Medicine·P J W H KappelleUNKNOWN PREVEND study group
Apr 5, 2011·Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association·Nosratola D VaziriHamid Moradi
Jul 28, 2012·American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation·Paul A SminkDick de Zeeuw
Apr 25, 2013·Journal of Renal Nutrition : the Official Journal of the Council on Renal Nutrition of the National Kidney Foundation·Hamid MoradiKamyar Kalantar-Zadeh
Aug 27, 2013·Clinical and Experimental Nephrology·Nosratola D Vaziri
May 24, 2014·Journal of the American Society of Nephrology : JASN·James P CorsettiRobin P F Dullaart
Aug 1, 2014·Clinical Biochemistry·Steven P MatyusTimothy J Fischer
Nov 17, 2015·Nature Reviews. Nephrology·Nosratola D Vaziri